Navigation Links
Rosetta Genomics Reports First Quarter 2008 Financial Results
Date:5/21/2008

Rosetta Genomics' technology in 2008, and Rosetta's expected cash usage in 2008 constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: the continued uncertainty in the credit and capital markets that may result in these markets deteriorating further or Rosetta experiencing additional ratings downgrades on any ongoing investments in its portfolio (including on ARS); changes in the accounting treatment and final results for 2007 resulting from final third party valuations of the ARS; the current lack of liquidity of the ARS having a impact on Rosetta's liquidity, cash flow or its ability to fund its operations; other changes in general economic and business conditions; Rosetta's approach to discover and develop novel diagnostics products, which is unproven and may never lead to marketable products or services; Rosetta's ability to fund and the results of further pre-clinical and clinical trials; Rosetta's ability to obtain, maintain and protect the intellectual property utilized by Rosetta's products; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products and services; the successful development of diagnostic and therapeutic products applying Rosetta's technology, all of which are in early stages of development; Rosetta's ability to obtain regulatory clearances or approvals for products, as may be required under applicable laws; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta'
'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... NEW YORK and SANTA CLARA, ... Health Corp. (NASDAQ: WBMD ), the leading ... a new WebMD/Medscape survey that provide novel ... role in aiding diagnosis and care.  Dr. Eric ... genomics and digital medicine, who serves as both Editor-in-Chief ...
(Date:9/22/2014)... by researchers at the USC Viterbi School of ... 3-D microfluidic system quickly and cheaply by simply ... Microfluidic systems are used in many fields including ... volumes of fluids for use in applications such ... diagnostic testing, and synthetic chemistry. Traditionally, microfluidic devices ...
(Date:9/22/2014)... Analysis of circulating tumor cells (CTCs) in a mouse ... expression in several groups of CTCs, including significant differences ... ability to generate metastases. In their study reported ... , investigators from the Massachusetts General Hospital (MGH) Cancer ... found unexpected factors that may prove to be targets ...
(Date:9/22/2014)... Minnesota electrical engineering researchers have developed a unique ... mechanical transportation of light. The discovery could have ... optical devices for computation and communication. , The ... computer engineering assistant professor Mo Li and his ... and will appear in the October issue of ...
Breaking Biology Technology:WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 2WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 3WebMD/Medscape Digital Technology Survey Reveals Unique Insights Into How Patients and Physicians Perceive the Role, Potential and Risks Associated with Digital Health Technologies 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 2Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 3Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 4Lego-like modular components make building 3-D 'labs-on-a-chip' a snap 5Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3Engineers show light can play seesaw at the nanoscale 2
... Students, faculty and supporters of The University of Texas ... state-of-the-art Engineering Research Building with a March 4 dedication ... ) The landmark center is UT ... by College of Engineering and College ...
... PITTSBURGH, March 1, 2011 D3 Oncology Solutions ... Via Oncology Pathways for medical oncology to the ... D3 now offers integrated pathways programs to both ... Via Oncology Pathways are evidence-based clinical algorithms that ...
... 2011 Iverson Genetic Diagnostics, Inc. announced today that the ... R eduction f or A dults R ... at WellStar Health System in Marietta and other major hospital ... determine a personalized warfarin dose for individual patients to reduce ...
Cached Biology Technology:UT Arlington Honors Collaborative Research During March 4 Engineering Research Building Dedication 2UT Arlington Honors Collaborative Research During March 4 Engineering Research Building Dedication 3D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology 2WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 2WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 3WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 4
(Date:9/22/2014)... 22, 2014Cassava, also known as tapioca, has large starch-filled ... of Africa, Asia, and Latin America where corn and ... novel enzymes and processes designed to break down tapioca ... produce sweeteners such as glucose, fructose, or maltose syrup, ... described in a Review article in Industrial Biotechnology ...
(Date:9/22/2014)... institutions in the country selected by the National ... BEST Award a $2 million grant designed ... biomedical sciences graduate trainees to career opportunities that ... traditionally taken. , The award funds development of ... (iJOBs) program. It includes courses, seminars, shadowing, mentoring ...
(Date:9/22/2014)... in the wake of the huge King Fire blazing ... The King Fire is burning in steep terrain in ... Creek Canyon, and the Rubicon Canyon, north of the ... Placer County and burned onto the Tahoe National Forest ... is expected to be minimal on Sept. 22 due ...
Breaking Biology News(10 mins):Rutgers receives $2 million grant to prepare biomedical students for roles in industry 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 3
... good chance that forest fires in the Pacific Northwest will ... expert speaking today at a professional conference, that,s just fine. ... to predict, will always be variable, and undoubtedly a part ... is not only inevitable but also a valuable part of ...
... feet were built the same way as a mongoose,s feet, they,d ... support the big cat,s weight. But they,re not. For decades, ... put together across the four-legged animal kingdom, but until now they ... foot that bear the brunt of the animal,s walking and running. ...
... particles called neutrons are poised to play a big ... manufacturing processes. The reason: They are the focus of ... to study the chemistry of a wide range of ... a fascinating article in Chemical & Engineering News ...
Cached Biology News:More frequent fires could aid ecosystems 2More frequent fires could aid ecosystems 3The bigger the animal, the stiffer the 'shoes' 2
... Blot Processing mini Tray (3 per ... gel staining and blot processing.Automated staining ... for proteins and nucleic acid analysis.Prepares ... and chromogenic detection.Programmable control of protocol, ...
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
... 1 g. High quality kits ... preparation that give consistent and ... and tissues.Clean up samples from ... Accurately quantitate protein for first-dimension ...
... Varian Cary 50 Microplate Reader ... cost per analysis by extending ... the award-winning Cary 50 instruments. ... to 384 samples in microlitre ...
Biology Products: